SIGA Technologies, Inc. announced that the U.S. Department of Health and Human Services exercised procurement options for the delivery of approximately $113 million worth of oral TPOXX treatment courses and approximately $25 million worth of IV TPOXX treatment courses. SIGA expects to fully deliver approximately $113 million of oral TPOXX under this order in 2023 and expects to start delivering IV TPOXX under this order In 2024. Prior to delivery of IV TPOXX under this orders, SIGA will be focused on fulfilling delivery obligations under a prior IV TPOXX order.

This project has been supported in whole or in part with federal funds from the U.S. Department the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA) and Strategic National Stockpile, under Contract No. 75A50118C00019.